Onbrez case: Delhi High Court reserves decision on Novartis-Cipla patent dispute

nDimensionsIP
Oct 6, 2015
1 min read

A division bench of the Delhi High Court has reserved its decision on a high-profile patent case that pitted Swiss drug maker Novartis against Cipla over its respiratory drug brand Onbrez.

#Cipla #Onbrez

Recent Posts

See All

General Motors gets Indian patent related to powertrain technology

General Motors has secured an Indian patent on a hybrid powertrain control system for vehicles. The patent rights are currently assigned...

Trademarks Office: Abandonment orders kept in abeyance

Taking into consideration the Delhi High court’s order staying the abandonment orders passed by the Trademarks Office, the Registrar of...

Delhi High Court: No “irreconcilable conflict” between the Competition Act and the Patents Act

The order of the Delhi High Court allows the Competition Commission of India (CCI) to attend to complaints on abuse of dominance of...

nDimensions IP

Onbrez case: Delhi High Court reserves decision on Novartis-Cipla patent dispute

Recent Posts

Hozzászólások

Working Hours

Contact Us